Bausch Health Companies (BHC) Change in Inventory (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Change in Inventory came in at $14.0 million in Q1 2026, down 53.33% year-on-year from $30.0 million in Q1 2025, and up 180.0% quarter-over-quarter from $5.0 million in Q4 2025.
Bausch Health Companies (BHC) Change in Inventory (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Change in Inventory across 18 years of filings, most recently posting $14.0 million for Q1 2026.
- Change in Inventory for Q1 2026 came in at $14.0 million, down 53.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 102.61% YoY), and the FY2025 annual result was $12.0 million, down 95.51% from the prior year.
- Change in Inventory came in at $14.0 million for Q1 2026 at Bausch Health Companies, up from $5.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $144.0 million in Q1 2024 to a low of -$16.0 million in Q3 2025.
- The 5-year median for Change in Inventory is $42.0 million (2024), against an average of $47.8 million.
- Across the five-year window, Change in Inventory jumped 2400.0% in 2023 and plunged 138.1% in 2025, its largest moves.
- Bausch Health Companies' Change in Inventory stood at $4.0 million in 2022, then surged by 2400.0% to $100.0 million in 2023, then plunged by 51.0% to $49.0 million in 2024, then sank by 89.8% to $5.0 million in 2025, then surged by 180.0% to $14.0 million in 2026.
- The last three Change in Inventory figures came in at $14.0 million (Q1 2026), $5.0 million (Q4 2025), and -$16.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 20.30 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -2.11 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 14.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 144.00 Mn |
| Mar 31, 2024 | 144.00 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Dec 31, 2023 | 100.00 Mn |